Search

Search Results
Results 7661 - 7670 of 7708 for Gastrointestinal
  • Agrylin
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Agrylin intended for persons living in Australia.
  • Cervagem
    Drug - 9 Aug 2022
    Consumer Medicine Information (CMI) about Cervagem intended for persons living in Australia.
  • Glivec Tablets
    Drug - 3 Aug 2022
    Consumer Medicine Information (CMI) about Glivec Tablets intended for persons living in Australia.
  • Inqovi
    Drug - 27 Jul 2022
    Consumer Medicine Information (CMI) about Inqovi intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Abyraz
    Drug - 19 Jul 2022
    Consumer Medicine Information (CMI) about Abyraz intended for persons living in Australia.
  • Perindo Combi
    Drug - 6 Jul 2022
    Consumer Medicine Information (CMI) about Perindo Combi (perindopril and indapamide) intended for persons living in Australia.
  • Bupivadren
    Drug - 4 Jul 2022
    Consumer Medicine Information (CMI) about Bupivadren intended for persons living in Australia.
  • Busulfex
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Busulfex intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback